Multifaceted regulation of T cells by CD44

References

• Ponta H, Sherman L, Herrlich P. CD44: From adhesion molecules to signaling regulators. Nat Rev Molec Cell Biol 2003; 4:33 - 45
   PubMed Web of Science ®Google Scholar
• Katoh S, Miyagi T, Taniguchi H, Matsubara Y, Kadota J, Tominaga A, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol 1999; 162:5058 - 5061
   PubMed Web of Science ®Google Scholar
• Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 1998; 140:431 - 446
   PubMed Web of Science ®Google Scholar
• Baaten BJ, Li CR, Deiro MF, Lin MM, Linton PJ, Bradley LM. CD44 regulates survival and memory development in Th1 cells. Immunity 2010; 32:104 - 115
   PubMed Web of Science ®Google Scholar
• Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 2009; 8:208 - 220
   PubMedGoogle Scholar
• Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Molec Med 2001; 7:213 - 221
   PubMed Web of Science ®Google Scholar
• Zoller M, McElwee KJ, Engel P, Hoffmann R. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 2002; 118:983 - 992
   PubMed Web of Science ®Google Scholar
• DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997; 159:2549 - 2553
   PubMed Web of Science ®Google Scholar
• Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells druing an in vivo immune response. J Exp Med 1994; 180:383 - 387
   PubMed Web of Science ®Google Scholar
• Ariel A, Lider O, Brill A, Cahalon L, Savion N, Varon D, et al. Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators. Immunology 2000; 100:345 - 351
   PubMed Web of Science ®Google Scholar
• Levesque MC, Haynes BF. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFNgamma. J Immunol 2001; 166:188 - 196
   PubMed Web of Science ®Google Scholar
• Levesque MC, Haynes BF. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNFalpha and is inhibited by IL-4 and IL-13. J Immunol 1997; 159:6184 - 6194
   PubMed Web of Science ®Google Scholar
• DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278:672 - 675
   PubMed Web of Science ®Google Scholar
• Marhaba R, Freyschmidt-Paul P, Zoller M. In vivo CD44-CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance. Eur J Immunol 2006; 36:3017 - 3032
   PubMed Web of Science ®Google Scholar
• Nandi A, Estess P, Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 2004; 20:455 - 465
   PubMed Web of Science ®Google Scholar
• Yago T, Shao B, Miner JJ, Yao L, Klopocki AG, Maeda K, et al. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood 2010; 116:485 - 494
   PubMed Web of Science ®Google Scholar
• Mrass P, Kinjyo I, Ng LG, Reiner SL, Pure E, Weninger W. CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity. Immunity 2008; 29:971 - 985
   PubMed Web of Science ®Google Scholar
• Bonder CS, Clark SR, Norman MU, Johnson P, Kubes P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood 2006; 107:4798 - 4806
   PubMed Web of Science ®Google Scholar
• Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004; 4:325 - 335
   PubMed Web of Science ®Google Scholar
• del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol 1995; 131:495 - 508
   PubMed Web of Science ®Google Scholar
• Rosenman SJ, Ganji AA, Tedder TF, Gallatin WM. Syncapping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells. J Leukoc Biol 1993; 53:1 - 10
   PubMed Web of Science ®Google Scholar
• Charrin S, Alcover A. Role of ERM (ezrin-radixin-moesin) proteins in T lymphocyte polarization, immune synapse formation and in T cell receptor-mediated signaling. Front Biosci 2006; 11:1987 - 1997
   PubMed Web of Science ®Google Scholar
• Sanchez-Madrid F, del Pozo MA. Leukocyte polarization in cell migration and immune interactions. EMBO J 1999; 18:501 - 511
   PubMed Web of Science ®Google Scholar
• Savinov AY, Rozanov DV, Golubkov VS, Wong FS, Strongin AY. Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas. J Biol Chem 2005; 280:27755 - 22758
   PubMed Web of Science ®Google Scholar
• Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, et al. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 2004; 165:893 - 902
   PubMed Web of Science ®Google Scholar
• Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95:930 - 935
   PubMed Web of Science ®Google Scholar
• Okamoto I, Kawano Y, Sasaki J, Nakao M, Matsumoto M, Suga M, et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999; 18:1435 - 1446
   PubMed Web of Science ®Google Scholar
• Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 2001; 155:755 - 762
   PubMed Web of Science ®Google Scholar
• Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer AK, et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 2002; 277:44754 - 44759
   PubMed Web of Science ®Google Scholar
• Thorne RF, Legg JW, Isacke CM. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J Cell Sci 2004; 117:373 - 380
   PubMed Web of Science ®Google Scholar
• Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol 2002; 169:4322 - 4331
   PubMed Web of Science ®Google Scholar
• Do Y, Nagarkatti PS, Nagarkatti M. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J Immunother 2004; 27:1 - 12
   PubMed Web of Science ®Google Scholar
• Hegde VL, Singh NP, Nagarkatti PS, Nagarkatti M. CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation. J Leukoc Biol 2008; 84:134 - 142
   PubMed Web of Science ®Google Scholar
• Pure E, Assoian RK. Rheostatic signaling by CD44 and hyaluronan. Cell Signal 2009; 21:651 - 655
   PubMed Web of Science ®Google Scholar
• Galandrini R, Galluzzo E, Albi N, Grossi CE, Velardi A. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol 1994; 153:21 - 31
   PubMed Web of Science ®Google Scholar
• Sugiyama K, Komada Y, Deguchi T, Zhang XL, Azuma E, Ido M, et al. CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region. Immunol Invest 1999; 28:185 - 200
   PubMed Web of Science ®Google Scholar
• Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, et al. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10 and TGFbeta. J Immunol 2009; 183:2232 - 2241
   PubMed Web of Science ®Google Scholar
• Nakano K, Saito K, Mine S, Matsushita S, Tanaka Y. Engagement of CD44 upregulates Fas Ligand expression on T cells leading to activation-induced cell death. Apoptosis 2007; 12:45 - 54
   PubMed Web of Science ®Google Scholar
• Ruffell B, Johnson P. Hyaluronan induces cell death in activated T cells through CD44. J Immunol 2008; 181:7044 - 7054
   PubMed Web of Science ®Google Scholar
• Lin YH, Yang-Yen HF. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 2001; 276:46024 - 46030
   PubMed Web of Science ®Google Scholar
• Wittig BM, Johansson B, Zoller M, Schwarzler C, Gunthert U. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 2000; 178:497 - 507
   Google Scholar
• Naor D, Nedvetski S. CD44 in rheumatoid arthritis. Arthritis Res Ther 2003; 5:105 - 115
   PubMed Web of Science ®Google Scholar
• Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol 2006; 177:268 - 279
   PubMed Web of Science ®Google Scholar
• Foger N, Marhaba R, Zoller M. CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur J Immunol 2000; 30:2888 - 2899
   PubMed Web of Science ®Google Scholar
• Lee JL, Wang MJ, Sudhir PR, Chen JY. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol Cell Biol 2008; 28:5710 - 5723
   PubMed Web of Science ®Google Scholar
• Rozsnyay Z. Signaling complex formation of CD44 with src-related kinases. Immunol Lett 1999; 68:101 - 108
   PubMed Web of Science ®Google Scholar
• Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST. Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem 1996; 271:2863 - 2867
   PubMed Web of Science ®Google Scholar
• Wong NK, Lai JC, Birkenhead D, Shaw AS, Johnson P. CD45 downregulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells. J Immunol 2008; 181:7033 - 7043
   PubMed Web of Science ®Google Scholar
• Varadhachary AS, Edidin M, Hanlon AM, Peter ME, Krammer PH, Salgame P. Phosphatidylinositol 3′-kinase blocks CD95 aggregation and caspase-8 cleavage at the death-inducing signaling complex by modulating lateral diffusion of CD95. J Immunol 2001; 166:6564 - 6569
   PubMed Web of Science ®Google Scholar
• Jones RG, Elford AR, Parsons MJ, Wu L, Krawczyk CM, Yeh WC, et al. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med 2002; 196:335 - 348
   PubMed Web of Science ®Google Scholar
• Bourguignon LY, Lokeshwar VB, Chen X, Kerrick WG. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 1993; 151:6634 - 6644
   PubMed Web of Science ®Google Scholar
• Su CC, Lin YP, Cheng YJ, Huang JY, Chuang WJ, Shan YS, et al. Phosphatidylinositol 3-kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells. J Immunol 2007; 179:4589 - 4597
   PubMed Web of Science ®Google Scholar
• Ward SG, Marelli-Berg FM. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J 2009; 418:13 - 27
   PubMed Web of Science ®Google Scholar
• Delgoffe GM, Powell JD. mTOR: taking cues from the immune microenvironment. Immunology 2009; 127:459 - 465
   PubMed Web of Science ®Google Scholar
• Zehntner SP, Bourbonniere L, Moore CS, Morris SJ, Methot D, St. Jean M, et al. X-linked inhibitor of apoptosis regulates T cell effector function. J Immunol 2007; 179:7553 - 7560
   PubMed Web of Science ®Google Scholar
• Song J, So T, Cheng M, Tang X, Croft M. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 2005; 22:621 - 631
   PubMed Web of Science ®Google Scholar
• Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N, et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 2010; 32:743 - 753
   PubMed Web of Science ®Google Scholar
• Varadhachary AS, Peter ME, Perdow SN, Krammer PH, Salgame P. Selective upregulation of phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. J Immunol 1999; 163:4772 - 4779
   PubMed Web of Science ®Google Scholar